Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

51 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Reduction of hepatic phosphoenolpyruvate carboxykinase (PEPCK) activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is due to decreased mRNA levels.
Stahl BU, Beer DG, Weber LW, Rozman K. Stahl BU, et al. Among authors: weber lw. Toxicology. 1993 Mar 30;79(1):81-95. doi: 10.1016/0300-483x(93)90207-9. Toxicology. 1993. PMID: 8475501
Correlation between toxicity and effects on intermediary metabolism in 2,3,7,8-tetrachlorodibenzo-p-dioxin-treated male C57BL/6J and DBA/2J mice.
Weber LW, Lebofsky M, Stahl BU, Smith S, Rozman KK. Weber LW, et al. Toxicol Appl Pharmacol. 1995 Mar;131(1):155-62. doi: 10.1006/taap.1995.1057. Toxicol Appl Pharmacol. 1995. PMID: 7878671
A pharmacodynamic model of triglyceride transport and deposition during feed deprivation or following treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the rat.
Roth WL, Weber LW, Stahl BU, Rozman K. Roth WL, et al. Among authors: weber lw. Toxicol Appl Pharmacol. 1993 May;120(1):126-37. doi: 10.1006/taap.1993.1095. Toxicol Appl Pharmacol. 1993. PMID: 8511774
Elevated plasma corticosterone levels and histopathology of the adrenals and thymuses in 2,3,7,8-tetrachlorodibenzo-p-dioxin-treated rats.
Gorski JR, Muzi G, Weber LW, Pereira DW, Iatropoulos MJ, Rozman K. Gorski JR, et al. Among authors: weber lw. Toxicology. 1988 Dec 16;53(1):19-32. doi: 10.1016/0300-483x(88)90233-8. Toxicology. 1988. PMID: 3201474
51 results
Jump to page
Feedback